UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phenotype-based drug screening reveals association between venetoclax response and differentiation stage in acute myeloid leukemia

Haematologica (Roma), 2020-03, Vol.105 (3), p.708-720

2020

Volltextzugriff (PDF)

Moxetumomab pasudotox in heavily pre-treated patients with relapsed/refractory hairy cell leukemia (HCL): long-term follow-up from the pivotal trial

Journal of hematology and oncology, 2021-02, Vol.14 (1), p.35-11, Article 35

2021

Volltextzugriff (PDF)

AML in the elderly—A global view

British journal of haematology, 2023-12, Vol.203 (5), p.760-773

2023

Volltextzugriff (PDF)

Tunneling nanotube (TNT) formation is downregulated by cytarabine and NF-κB inhibition in acute myeloid leukemia (AML)

Oncotarget, 2017-01, Vol.8 (5), p.7946-7963

2017

Volltextzugriff (PDF)

JAK1/2 and BCL2 inhibitors synergize to counteract bone marrow stromal cell–induced protection of AML

Blood, 2017-08, Vol.130 (6), p.789-802

2017

Volltextzugriff (PDF)

Multi-parametric single cell evaluation defines distinct drug responses in healthy hematologic cells that are retained in corresponding malignant cell types

Haematologica (Roma), 2020-06, Vol.105 (6), p.1527-1538

2020

Volltextzugriff (PDF)

Pan-RAF inhibition induces apoptosis in acute myeloid leukemia cells and synergizes with BCL2 inhibition

Leukemia, 2020-12, Vol.34 (12), p.3186-3196

2020

Volltextzugriff (PDF)

Sex disparity in acute myeloid leukaemia with FLT3 internal tandem duplication mutations: implications for prognosis

Molecular oncology, 2021-09, Vol.15 (9), p.2285-2299

2021

Volltextzugriff (PDF)

Drug Repurposing for the Treatment of Acute Myeloid Leukemia

Frontiers in medicine, 2017-11, Vol.4, p.211-211

2017

Volltextzugriff (PDF)

Clinical Trials of Repurposing Medicines in Acute Myeloid Leukemia: Limitations and Possibilities in the Age of Precision Therapy

The cancer journal (Sudbury, Mass.), 2019-03, Vol.25 (2), p.153-163

2019

Volltextzugriff (PDF)

Reduced CD62L Expression on T Cells and Increased Soluble CD62L Levels Predict Molecular Response to Tyrosine Kinase Inhibitor Therapy in Early Chronic-Phase Chronic Myelogenous Leukemia

Journal of clinical oncology, 2017-01, Vol.35 (2), p.175-184

2017

Volltextzugriff (PDF)

FLT3‐ITD mutations in acute myeloid leukaemia – molecular characteristics, distribution and numerical variation

Molecular oncology, 2021-09, Vol.15 (9), p.2300-2317

2021

Volltextzugriff (PDF)

Single Cell Profiling of Potentiated Phospho-Protein Networks in Cancer Cells

Cell, 2004-07, Vol.118 (2), p.217-228

2004

Volltextzugriff (PDF)

Single-cell proteomics: potential implications for cancer diagnostics

Expert review of molecular diagnostics, 2016-05, Vol.16 (5), p.579-589

2016

Volltextzugriff (PDF)

Signaling effects of sodium hydrosulfide in healthy donor peripheral blood mononuclear cells

Pharmacological research, 2016-11, Vol.113 (Pt A), p.216-227

2016

Volltextzugriff (PDF)

Expression profile of heat shock proteins in acute myeloid leukaemia patients reveals a distinct signature strongly associated with FLT3 mutation status - consequences and potentials for pharmacological intervention

British journal of haematology, 2012-02, Vol.156 (4), p.468-480

2012

Volltextzugriff (PDF)

Development of Personalized Molecular Therapy for Acute Myeloid Leukemia

Current pharmaceutical biotechnology, 2016, Vol.17 (1), p.20-29

2016

Volltextzugriff (PDF)

CD24-targeted fluorescence imaging in patient-derived xenograft models of high-grade serous ovarian carcinoma

EBioMedicine, 2020-06, Vol.56, p.102782-102782, Article 102782

2020

Volltextzugriff (PDF)

Monosomy 7/del(7q) cause sensitivity to inhibitors of nicotinamide phosphoribosyltransferase in acute myeloid leukemia

Blood advances, 2024-04, Vol.8 (7), p.1621-1633

2024

Volltextzugriff (PDF)

Bimodal expression of potential drug target CLL‐1 (CLEC12A) on CD34+ blasts of AML patients

European journal of haematology, 2021-09, Vol.107 (3), p.343-353

2021

Volltextzugriff (PDF)

Assessment of postoperative circulating tumour DNA to predict early recurrence in patients with stage I–III right-sided colon cancer: prospective observational study

BJS open, 2024-01, Vol.8 (1)

2024

Volltextzugriff (PDF)

Anti-proliferative activity of the NPM1 interacting natural product avrainvillamide in acute myeloid leukemia

Cell death & disease, 2016-12, Vol.7 (12), p.e2497-e2497

2016

Volltextzugriff (PDF)

Primary human acute myeloid leukaemia cells increase the proliferation of microvascular endothelial cells through the release of soluble mediators

British journal of haematology, 2009-01, Vol.144 (1), p.53-68

2009

Volltextzugriff (PDF)

1 – 25 von 404

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(374)
Mit Volltextzugriff
(355)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(247)
Life Sciences & Biomedicine
(230)
Humans
(179)
Oncology
(88)
Female
(83)
Hematology
(82)
Male
(80)
Adult
(62)
Middle Aged
(60)
Aged
(52)
Animals
(50)
Leukemia
(50)
Chemotherapy
(45)
Leukemia, Myeloid, Acute - Drug Therapy
(42)
Apoptosis
(39)
Acute Myeloid Leukemia
(38)
Aged, 80 And Over
(37)
Leukemia, Myeloid, Acute - Pathology
(35)
Biological And Medical Sciences
(34)
Cancer
(34)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(73)
Journal Of Clinical Oncology
(15)
Haematologica
(10)
Hemasphere
(10)
Leukemia
(10)
British Journal Of Haematology
(9)
Cancer Immunology, Immunotherapy
(9)
Cancer Immunology Immunotherapy
(8)
Cancer Research
(7)
Current Pharmaceutical Biotechnology
(7)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Phenotype-based drug screening reveals association between venetoclax response and differentiation stage in acute myeloid leukemia

Moxetumomab pasudotox in heavily pre-treated patients with relapsed/refractory hairy cell leukemia (HCL): long-term follow-up from the pivotal trial

Individualized systems medicine strategy to tailor treatments for patients with chemorefractory acute myeloid leukemia

AML in the elderly—A global view

Tunneling nanotube (TNT) formation is downregulated by cytarabine and NF-κB inhibition in acute myeloid leukemia (AML)

JAK1/2 and BCL2 inhibitors synergize to counteract bone marrow stromal cell–induced protection of AML

Multi-parametric single cell evaluation defines distinct drug responses in healthy hematologic cells that are retained in corresponding malignant cell types

Pan-RAF inhibition induces apoptosis in acute myeloid leukemia cells and synergizes with BCL2 inhibition

Sex disparity in acute myeloid leukaemia with FLT3 internal tandem duplication mutations: implications for prognosis

Drug Repurposing for the Treatment of Acute Myeloid Leukemia

Clinical Trials of Repurposing Medicines in Acute Myeloid Leukemia: Limitations and Possibilities in the Age of Precision Therapy

Reduced CD62L Expression on T Cells and Increased Soluble CD62L Levels Predict Molecular Response to Tyrosine Kinase Inhibitor Therapy in Early Chronic-Phase Chronic Myelogenous Leukemia

FLT3‐ITD mutations in acute myeloid leukaemia – molecular characteristics, distribution and numerical variation

Single Cell Profiling of Potentiated Phospho-Protein Networks in Cancer Cells

Prospective validation of the prognostic relevance of CD34+CD38– AML stem cell frequency in the HOVON-SAKK132 trial

Single-cell proteomics: potential implications for cancer diagnostics

Signaling effects of sodium hydrosulfide in healthy donor peripheral blood mononuclear cells

Expression profile of heat shock proteins in acute myeloid leukaemia patients reveals a distinct signature strongly associated with FLT3 mutation status - consequences and potentials for pharmacological intervention

Development of Personalized Molecular Therapy for Acute Myeloid Leukemia

CD24-targeted fluorescence imaging in patient-derived xenograft models of high-grade serous ovarian carcinoma

Monosomy 7/del(7q) cause sensitivity to inhibitors of nicotinamide phosphoribosyltransferase in acute myeloid leukemia

Bimodal expression of potential drug target CLL‐1 (CLEC12A) on CD34+ blasts of AML patients

Assessment of postoperative circulating tumour DNA to predict early recurrence in patients with stage I–III right-sided colon cancer: prospective observational study

Anti-proliferative activity of the NPM1 interacting natural product avrainvillamide in acute myeloid leukemia

Primary human acute myeloid leukaemia cells increase the proliferation of microvascular endothelial cells through the release of soluble mediators

Suchergebnisse filtern